Skip to content

Welcome to the 60th
EMWA Conference!

We are delighted to welcome you to the 60th EMWA Conference, taking place virtually this autumn. As we mark this milestone event, we invite you to join us online for a rich and flexible programme designed to support medical writers at every stage of their careers.
Booking is for EMWA members

Browse and fill a basket without an account. You must sign in as a member before you can check out.

«Back to the programme
Session

How to AI-proof your medical writing career

Monday 9 November 2026 · 11:00-12:30 CET · Barry Drees and Tim Hardman and Namrata Singh and To be confirmed

Who it is for

Target audience: Medical writers (all levels)

What it covers

The session will act as a guide to support medical writers with how to effectively integrate AI into their working practices at the same time as developing the human-specific writing skills needed to effectively operate in a changing environment.
Context: Medical writing is evolving with AI, which can automate routine tasks but struggles with complex scientific judgment and strategy. Medical writers should focus on roles that leverage human expertise and strategic skills to direct, validate, and contextualize AI-generated content.
AI automates routine tasks: AI can produce outlines and first drafts, summarize studies, edit grammar, extract information, and generate standard medical communications, potentially impacting writers focused on these tasks.
Human skills remain essential: AI struggles with scientific judgment, critical appraisal, regulatory nuances, adapting messaging, publication strategy, relationship building, and ensuring ethical integrity, where medical writers can differentiate themselves.
Future-proofing careers: Writers should become AI-enabled, deepen scientific expertise, engage in strategy, excel at expert review, and develop interpersonal and leadership skills to thrive in transformed medical writing roles.

Workshop leaders
Barry Drees
Tim Hardman

Dr Tim Hardman is Founder and Managing Director of Niche Science & Technology Ltd., the UK-based CRO he established in 1998 to provide tailored, science-driven support to pharmaceutical and biotech companies. With more than 25 years’ experience in clinical research, he has built Niche into a trusted early-phase development partner for start-ups and established companies worldwide. Tim is Chairman of the Association of Human Pharmacology in the Pharmaceutical Industry (AHPPI) and a Board member and former President of EUFEMED (2021–2023). He also contributes to the Pharmaceutical Contract Management Group (PCMG) and holds an honorary fellowship at St George’s Medical School. He regularly comments on clinical research, regulatory innovation and AI.

Namrata Singh

Dr Namrata Singh is a paediatrician, medical writer, and entrepreneur with more than 20 years of experience across clinical practice, regulatory writing, and scientific communications. As Founder and CEO of Turacoz Group, an ISO-certified medical communications company, she leads teams that support pharmaceutical, biotech, and MedTech clients worldwide with publications, clinical trial documentation, and medical education. In this role she is closely involved in how AI is changing medical writing in practice, including how teams can use these tools responsibly while keeping scientific accuracy, transparency, and ethical publication standards. She is President-Elect of the European Medical Writers Association (EMWA). She holds an MBA and is based in Utrecht, the Netherlands.

To be confirmed

Workshop leader or speaker details will be added by EMWA head office.

Back To Top
Your Cart

Your cart is empty.